PAZOPANIB INTERMEDIATES

VIDGASTECH provides Pazopanib Intermediates with superior purity and stability, supporting the synthesis of VEGFR inhibitors for advanced cancer treatment.

Additional Content with Keywords:
VIDGASTECH specializes in pharmaceutical-grade Pazopanib API intermediates, essential for the production of VEGFR tyrosine kinase inhibitors used in renal cell carcinoma (RCC) and soft tissue sarcoma (STS) treatment. With strict GMP compliance, high-purity synthesis, and quality control, our intermediates ensure efficiency in oncology drug development. As a trusted supplier of Pazopanib intermediates, we provide reliable solutions for global pharmaceutical companies developing targeted cancer therapies. Contact us for bulk API intermediates and custom synthesis support.

2,3-dimethyl-6-nitro-2H-indazole 444731-73-1

2,3-dimethyl-2H-indazol-6-amine hydrochloride 635702-60-2

2,4-dichloropyrimidine 3934-20-1

N-(2-chloropyrimidin-4-yl)-2,3- dimethyl- 2H-indazol-6- amine 444731-74-2

13 N-(2-chloropyrimidin-4-yl)-N,2,3- trimethyl-2H- indazol 6-amine

444731-75-3

14 5-amino-2- methylbenzenesulfonamide 6973-09-7